Deregulation of DNA double-strand break repair in multiple myeloma: Implications for genome stability

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Herrero, Ana B ^a   SanMiguel, Jesús ^b   Gutierrez, Norma C ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; HISTONE H2AX; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAD51 PROTEIN; XRCC4 PROTEIN;

ARTICLE; CELL ISOLATION; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE CHECKPOINT; DNA END JOINING REPAIR; DNA REPAIR; DOUBLE STRANDED DNA BREAK; G2 PHASE CELL CYCLE CHECKPOINT; GENE DELETION; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IN VIVO STUDY; IONIZING RADIATION; LYMPHOBLASTOID CELL; MULTIPLE MYELOMA; MULTIPLE MYELOMA CELL LINE; MYELOMA CELL; PROTEIN ANALYSIS; RADIOSENSITIVITY; SEQUENCE HOMOLOGY; UPREGULATION; CELL SURVIVAL; GENETICS; M PHASE CELL CYCLE CHECKPOINT; PATHOLOGY; RADIATION RESPONSE; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; DNA REPAIR; G2 PHASE CELL CYCLE CHECKPOINTS; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MULTIPLE MYELOMA; UP-REGULATION;

EID: 84925400720     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121581     Document Type: Article

References (57)

1. Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma. Nat Rev Cancer. 2012; 12: 335-48. doi: 10.1038/nrc3257 PMID: 22495321
2. Chng WJ, Fonseca R. Centrosomes and myeloma; aneuploidy and proliferation. Environmental and molecular mutagenesis. 2009; 50: 697-707. doi: 10.1002/em.20528 PMID: 19739237
3. Diaz-Rodriguez E, Alvarez-Fernandez S, Chen X, Paiva B, Lopez-Perez R, Garcia-Hernandez JL, et al. Deficient spindle assembly checkpoint in multiple myeloma. PloS one. 2011; 6: e27583. doi: 10.1371/journal.pone.0027583 PMID: 22132115
4. Yuan J, Adamski R, Chen J. Focus on histone variant H2AX: To be or not to be. FEBS letters. 2010; 584: 3717-24. doi: 10.1016/j.febslet.2010.05.021 PMID: 20493860
5. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000; 10: 886-95. PMID: 10959836
6. Cahill D, Connor B, Carney JP. Mechanisms of eukaryotic DNA double strand break repair. Frontiers in bioscience: a journal and virtual library. 2006; 11: 1958-76. PMID: 16368571
7. Lieber MR. The mechanism of human nonhomologous DNA end joining. J Biol Chem. 2008; 283: 1-5. PMID: 17999957
8. Rothkamm K, Kruger I, Thompson LH, Lobrich M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol. 2003; 23: 5706-15. PMID: 12897142
9. Pierce AJ, Jasin M. NHEJ deficiency and disease. Mol Cell. 2001; 8: 1160-1. PMID: 11885597
10. Helleday T. Homologous recombination in cancer development, treatment and development of drug resistance. Carcinogenesis. 2010; 31: 955-60. doi: 10.1093/carcin/bgq064 PMID: 20351092
11. Chakraborty S, Stark JM, Sun CL, Modi H, Chen W, O'Connor TR, et al. Chronic myelogenous leukemia stem and progenitor cells demonstrate chromosomal instability related to repeated breakage-fusion-bridge cycles mediated by increased nonhomologous end joining. Blood. 2012; 119: 6187-97. doi: 10.1182/blood-2011-05-352252 PMID: 22493298
12. Bishop AJ, Schiestl RH. Homologous recombination as a mechanism of carcinogenesis. Biochim Biophys Acta. 2001; 1471: M109-21. PMID: 11250067
13. Mladenov E, Iliakis G. Induction and repair of DNA double strand breaks: The increasing spectrum of non-homologous end joining pathways. Mutation research. 2011; 711: 61-72. doi: 10.1016/j.mrfmmm. 2011.02.005 PMID: 21329706
14. Nussenzweig A, Nussenzweig MC. A backup DNA repair pathway moves to the forefront. Cell. 2007; 131: 223-5. PMID: 17956720
15. Kotnis A, Du L, Liu C, Popov SW, Pan-Hammarstrom Q. Non-homologous end joining in class switch recombination: The beginning of the end. Philos Trans R Soc Lond B Biol Sci. 2009; 364: 653-65. doi: 10.1098/rstb.2008.0196 PMID: 19008195
16. Yan CT, Boboila C, Souza EK, Franco S, Hickernell TR, Murphy M, et al. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature. 2007; 449: 478-82. PMID: 17713479
17. Corneo B, Wendland RL, Deriano L, Cui X, Klein IA, Wong SY, et al. Rag mutations reveal robust alternative end joining. Nature. 2007; 449: 483-6. PMID: 17898768
18. Olive PL, Banath JP. The comet assay: A method to measure DNA damage in individual cells. Nat Protoc. 2006; 1: 23-9. PMID: 17406208
19. Gyori BM, Venkatachalam G, Thiagarajan PS, Hsu D, Clement MV. OpenComet: An automated tool for comet assay image analysis. Redox Biol. 2014; 2: 457-65. doi: 10.1016/j.redox.2013.12.020 PMID: 24624335
20. Seluanov A, Mittelman D, Pereira-Smith OM, Wilson JH, Gorbunova V. DNA end joining becomes less efficient and more error-prone during cellular senescence. Proc Natl Acad Sci U S A. 2004; 101: 7624-9. PMID: 15123826
21. Kovala AT, Harvey KA, McGlynn P, Boguslawski G, Garcia JG, English D. High-efficiency transient transfection of endothelial cells for functional analysis. FASEB J. 2000; 14: 2486-94. PMID: 11099466
22. Mao Z, Bozzella M, Seluanov A, Gorbunova V. Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (Amst). 2008; 7: 1765-71. doi: 10.1016/j.dnarep.2008.06.018 PMID: 18675941
23. Lobrich M, Shibata A, Beucher A, Fisher A, Ensminger M, Goodarzi AA, et al. gammaH2AX foci analysis for monitoring DNA double-strand break repair: Strengths, limitations and optimization. Cell cycle. 2010; 9: 662-9. PMID: 20139725
24. Walters DK, Wu X, Tschumper RC, Arendt BK, Huddleston PM, Henderson KJ, et al. Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX. Leukemia. 2011; 25: 1344-53. doi: 10.1038/leu.2011.94 PMID: 21566653
25. Banath JP, Macphail SH, Olive PL. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res. 2004; 64: 7144-9. PMID: 15466212
26. Deckbar D, Jeggo PA, Lobrich M. Understanding the limitations of radiation-induced cell cycle checkpoints. Critical reviews in biochemistry and molecular biology. 2011; 46: 271-83. doi: 10.3109/10409238.2011.575764 PMID: 21524151
27. Busby EC, Leistritz DF, Abraham RT, Karnitz LM, Sarkaria JN. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1. Cancer research. 2000; 60: 2108-12. PMID: 10786669
28. Sarkaria JN, Tibbetts RS, Busby EC, Kennedy AP, Hill DE, Abraham RT. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer research. 1998; 58: 4375-82. PMID: 9766667
29. Qi W, Qiao D, Martinez JD. Caffeine induces TP53-independent G(1)-phase arrest and apoptosis in human lung tumor cells in a dose-dependent manner. Radiation research. 2002; 157: 166-74. PMID: 11835680
30. Klokov D, MacPhail SM, Banath JP, Byrne JP, Olive PL. Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiother Oncol. 2006; 80: 223-9. PMID: 16905207
31. Banath JP, Klokov D, MacPhail SH, Banuelos CA, Olive PL. Residual gammaH2AX foci as an indication of lethal DNA lesions. BMC Cancer. 2010; 10: 4. doi: 10.1186/1471-2407-10-4 PMID: 20051134
32. Olive PL. Retention of gammaH2AX foci as an indication of lethal DNA damage. Radiother Oncol. 2010; 101: 18-23.
33. Sallmyr A, Tomkinson AE, Rassool FV. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: Consequences for the repair of DNA double-strand breaks. Blood. 2008; 112: 1413-23. doi: 10.1182/blood-2007-07-104257 PMID: 18524993
34. Liang L, Deng L, Nguyen SC, Zhao X, Maulion CD, Shao C, et al. Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks. Nucleic Acids Res. 2008; 36: 3297-310. doi: 10.1093/nar/gkn184 PMID: 18440984
35. Audebert M, Salles B, Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem. 2004; 279: 55117-26. PMID: 15498778
36. Wang H, Rosidi B, Perrault R, Wang M, Zhang L, Windhofer F, et al. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res. 2005; 65: 4020-30. PMID: 15899791
37. Simsek D, Brunet E, Wong SY, Katyal S, Gao Y, McKinnon PJ, et al. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet. 2011; 7: e1002080. doi: 10.1371/journal.pgen.1002080 PMID: 21655080
38. Dupre A, Boyer-Chatenet L, Sattler RM, Modi AP, Lee JH, Nicolette ML, et al. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol. 2008; 4: 119-125. doi: 10.1038/nchembio.63 PMID: 18176557
39. Della-Maria J, Zhou Y, Tsai MS, Kuhnlein J, Carney JP, Paull TT, et al. Human Mre11/human Rad50/Nbs1 and DNA ligase IIIalpha/XRCC1 protein complexes act together in an alternative nonhomologous end joining pathway. J Biol Chem; 286: 33845-53. doi: 10.1074/jbc.M111.274159 PMID: 21816818
40. Wang M, Wu W, Rosidi B, Zhang L, Wang H, Iliakis G. PARP-1 and ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res. 2006; 34: 6170-82. PMID: 17088286
41. Magin S, Saha J, Wang M, Mladenova V, Coym N, Iliakis G. Lipofection and nucleofection of substrate plasmid can generate widely different readings of DNA end-joining efficiency in different cell lines. DNA Repair (Amst). 2013; 12: 148-60. doi: 10.1016/j.dnarep.2012.11.008 PMID: 23286905
42. Jeggo PA, Lobrich M. DNA double-strand breaks: Their cellular and clinical impact? Oncogene. 2007; 26: 7717-9. PMID: 18066083
43. Yang C, Betti C, Singh S, Toor A, Vaughan A. Impaired NHEJ function in multiple myeloma. Mutat Res. 2009; 660: 66-73. doi: 10.1016/j.mrfmmm.2008.10.019 PMID: 19028508
44. Kalocsay M, Hiller NJ, Jentsch S. Chromosome-wide Rad51 spreading and SUMO-H2A.Z-dependent chromosome fixation in response to a persistent DNA double-strand break. Mol Cell. 2009; 33: 335-43. doi: 10.1016/j.molcel.2009.01.016 PMID: 19217407
45. Wang X, Li GC, Iliakis G, Wang Y. Ku affects the CHK1-dependent G(2) checkpoint after ionizing radiation. Cancer research. 2002; 62: 6031-4. PMID: 12414624
46. Roddam PL, Allan JM, Dring AM, Worrillow LJ, Davies FE, Morgan GJ. Non-homologous end-joining gene profiling reveals distinct expression patterns associated with lymphoma and multiple myeloma. Br J Haematol. 2010; 149: 258-62. doi: 10.1111/j.1365-2141.2010.08088.x PMID: 20148879
47. Willmore E, Elliott SL, Mainou-Fowler T, Summerfield GP, Jackson GH, O'Neill F, et al. DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia. Clin Cancer Res. 2008; 14: 3984-92. doi: 10.1158/1078-0432.CCR-07-5158 PMID: 18559621
48. Richardson C, Stark JM, Ommundsen M, Jasin M. Rad51 overexpression promotes alternative doublestrand break repair pathways and genome instability. Oncogene. 2004; 23: 546-53. PMID: 14724582
49. Francis R, Richardson C. Multipotent hematopoietic cells susceptible to alternative double-strand break repair pathways that promote genome rearrangements. Genes Dev. 2007; 21: 1064-74. PMID: 17473170
50. Slupianek A, Nowicki MO, Koptyra M, Skorski T. BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells. DNA Repair (Amst). 2006; 5: 243-50. PMID: 16297667
51. Shammas MA, Shmookler Reis RJ, Koley H, Batchu RB, Li C, Munshi NC. Dysfunctional homologous recombination mediates genomic instability and progression in myeloma. Blood. 2009; 113: 2290-7. doi: 10.1182/blood-2007-05-089193 PMID: 19050310
52. Fan J, Li L, Small D, Rassool F. Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: Implications for genomic instability and therapy. Blood. 2010; 116: 5298-305. doi: 10.1182/blood-2010-03-272591 PMID: 20807885
53. Luoto KR, Meng AX, Wasylishen AR, Zhao H, Coackley CL, Penn LZ, et al. Tumor cell kill by c-MYC depletion: Role of MYC-regulated genes that control DNA double-strand break repair. Cancer Res. 2010; 70: 8748-59. doi: 10.1158/0008-5472.CAN-10-0944 PMID: 20940401
54. Volcic M, Karl S, Baumann B, Salles D, Daniel P, Fulda S, et al. NF-kappaB regulates DNA doublestrand break repair in conjunction with BRCA1-CtIP complexes. Nucleic Acids Res. 2012; 40: 181-95. doi: 10.1093/nar/gkr687 PMID: 21908405
55. Hahnel PS, Enders B, Sasca D, Roos WP, Kaina B, Bullinger L, et al. Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy. Blood. 2014; 123: 2355-66. doi: 10.1182/blood-2013-01-477620 PMID: 24505083
56. Tobin LA, Robert C, Rapoport AP, Gojo I, Baer MR, Tomkinson AE, et al. Targeting abnormal DNA dou-ble- strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias. Oncogene. 2012; 32: 1784-93. doi: 10.1038/onc.2012.203 PMID: 22641215
57. Garrett MD, Collins I. Anticancer therapy with checkpoint inhibitors: What, where and when? Trends Pharmacol Sci. 2011; 32: 308-16. doi: 10.1016/j.tips.2011.02.014 PMID: 21458083